David A. Morrow, M.D., M.P.H. NEJM Volume 361:913-915 August 27, 2009 Number 9
Despite the pervasive measurement of cardiac troponin for the diagnosis of myocardial infarction, the continued evolution of assays and guidelines for their application has created uncertainty among many practitioners regarding the use of cutoff values for clinical interpretation.
Go to NEJM here.